Current Events

News Report

Published:2016-09-07 Views:6

    On 2nd Sept. 2016, Medical Economics, the authoritative media in China pharmaceutical industry, published bylined articles “Speeding up hydroxyethyl starch substitution from importing to domestic manufacturing”, reported our leading product of hydroxyethyl starch 130/0.4 had obtained CEP certificates. It pointed out that EDQM only issued 3 CEP certificates of HES130/0.4 globally, and this is the first one awarded to Chinese manufacturer.